Interesting ImagesFDG PET/CT in a Pregnant Woman With Breast CancerDrouet, Clément MD∗; Vrigneaud, Jean-Marc PhD∗,†; Desmoulins, Isabelle MD‡; Cochet, Alexandre MD, PhD∗,†Author Information From the ∗Nuclear Medicine Department, Centre Georges François Leclerc †ImVIA Laboratory, EA 7535, University of Burgundy ‡Oncology Department, Centre Georges François Leclerc, Dijon, France. Received for publication January 22, 2020; revision accepted February 28, 2020. Conflicts of interest and sources of funding: none declared. Correspondence to: Clément Drouet, MD, Nuclear Medicine Department, Centre Georges François Leclerc, 1 rue du Pr Marion, 21 000 Dijon, France. E-mail: email@example.com. Clinical Nuclear Medicine: July 2020 - Volume 45 - Issue 7 - p e339-e341 doi: 10.1097/RLU.0000000000003045 Buy Metrics Abstract This 37-year-old woman was diagnosed with breast cancer during pregnancy. After multidisciplinary meeting, she was referred to our department for an FDG PET/CT for staging, and chemotherapy with weekly infusion of paclitaxel was initiated before childbirth. We estimated the fetal dose from the PET/CT procedure, and our results show that, if deemed necessary, this examination can reasonably be performed during pregnancy. The patient gave birth vaginally at term to an apparently healthy girl. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.